go back

Alaska rates for HCPCS Q2053

Brexucabtagene autoleucel, up to 200 million autologous anti-CD19 CAR positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $537,032 · 10th–90th $489,779–$1,230,2690%50%10th90th$537,032Professionalmedian $489,779 · 10th–90th $489,779–$588,8440%50%90th$489,779$0.1$1.0$20.0$500.0$10.0K$200.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$3,162,277.66 / $3,162,277.66 / $3,162,277.66
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$489,778.82 / $489,778.82 / $537,031.80
Moda Health
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$489,778.82 / $537,031.80 / $1,230,268.77
Moda Health
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$489,778.82 / $588,843.66 / $1,230,268.77
Premera BCBS
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$741,310.24 / $776,247.12 / $1,230,268.77
Premera BCBS
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$549,540.87 / $660,693.45 / $660,693.45
Providence
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$489,778.82 / $537,031.80 / $912,010.84
Providence
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$60.26 / $616,595.00 / $676,082.98
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$489,778.82 / $512,861.38 / $812,830.52